Cargando…

Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies

A ubiquitous post-translational modification observed in proteins is isomerization of aspartic acid to isoaspartic acid (isoAsp). This non-enzymatic post-translational modification occurs spontaneously in proteins and plays a role in aging, autoimmune response, cancer, neurodegeneration, and other d...

Descripción completa

Detalles Bibliográficos
Autores principales: Eakin, Catherine M., Miller, Amanda, Kerr, Jennifer, Kung, James, Wallace, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010776/
https://www.ncbi.nlm.nih.gov/pubmed/24808864
http://dx.doi.org/10.3389/fphar.2014.00087
_version_ 1782479905130283008
author Eakin, Catherine M.
Miller, Amanda
Kerr, Jennifer
Kung, James
Wallace, Alison
author_facet Eakin, Catherine M.
Miller, Amanda
Kerr, Jennifer
Kung, James
Wallace, Alison
author_sort Eakin, Catherine M.
collection PubMed
description A ubiquitous post-translational modification observed in proteins is isomerization of aspartic acid to isoaspartic acid (isoAsp). This non-enzymatic post-translational modification occurs spontaneously in proteins and plays a role in aging, autoimmune response, cancer, neurodegeneration, and other diseases. Formation of isoAsp is also a significant issue for recombinant monoclonal antibody based protein therapeutics particularly when isomerization occurs in a complementarity-determining region due to potential impact to the clinical efficacy. Here, we present and compare three analytical methods to monitor and/or quantify isoAsp formation in a monoclonal antibody. The methods include two peptide map based technologies with quantitation from either UV integration or total ion peak areas, as well as an alternative approach using IdeS digestion to generate Fc/2 and Fab’2 regions, followed by hydrophobic interaction chromatography (HIC) to separate the population of Fab’2 containing an isoAsp. The level of isoAsp detected by the peptide map and the digested-HIC methods presented here show similar trends although sample throughput varies by method.
format Online
Article
Text
id pubmed-4010776
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40107762014-05-07 Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies Eakin, Catherine M. Miller, Amanda Kerr, Jennifer Kung, James Wallace, Alison Front Pharmacol Pharmacology A ubiquitous post-translational modification observed in proteins is isomerization of aspartic acid to isoaspartic acid (isoAsp). This non-enzymatic post-translational modification occurs spontaneously in proteins and plays a role in aging, autoimmune response, cancer, neurodegeneration, and other diseases. Formation of isoAsp is also a significant issue for recombinant monoclonal antibody based protein therapeutics particularly when isomerization occurs in a complementarity-determining region due to potential impact to the clinical efficacy. Here, we present and compare three analytical methods to monitor and/or quantify isoAsp formation in a monoclonal antibody. The methods include two peptide map based technologies with quantitation from either UV integration or total ion peak areas, as well as an alternative approach using IdeS digestion to generate Fc/2 and Fab’2 regions, followed by hydrophobic interaction chromatography (HIC) to separate the population of Fab’2 containing an isoAsp. The level of isoAsp detected by the peptide map and the digested-HIC methods presented here show similar trends although sample throughput varies by method. Frontiers Media S.A. 2014-04-29 /pmc/articles/PMC4010776/ /pubmed/24808864 http://dx.doi.org/10.3389/fphar.2014.00087 Text en Copyright © 2014 Eakin, Miller, Kerr, Kung and Wallace. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Eakin, Catherine M.
Miller, Amanda
Kerr, Jennifer
Kung, James
Wallace, Alison
Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title_full Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title_fullStr Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title_full_unstemmed Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title_short Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies
title_sort assessing analytical methods to monitor isoasp formation in monoclonal antibodies
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010776/
https://www.ncbi.nlm.nih.gov/pubmed/24808864
http://dx.doi.org/10.3389/fphar.2014.00087
work_keys_str_mv AT eakincatherinem assessinganalyticalmethodstomonitorisoaspformationinmonoclonalantibodies
AT milleramanda assessinganalyticalmethodstomonitorisoaspformationinmonoclonalantibodies
AT kerrjennifer assessinganalyticalmethodstomonitorisoaspformationinmonoclonalantibodies
AT kungjames assessinganalyticalmethodstomonitorisoaspformationinmonoclonalantibodies
AT wallacealison assessinganalyticalmethodstomonitorisoaspformationinmonoclonalantibodies